| Literature DB >> 35892647 |
Ana Luiza Amaral1, Jaqueline Pontes Batista1, Igor Moraes Mariano1, Ludimila Ferreira Gonçalves1, Júlia Buiatte Tavares1, Adriele Vieira de Souza2, Douglas C Caixeta2, Renata R Teixeira2, Erick P de Oliveira3, Foued S Espindola2, Guilherme Morais Puga1.
Abstract
Postmenopausal women have a high prevalence of cardiometabolic diseases and that may associate with higher oxidative stress. Exercise can contribute to the treatment of such diseases, but some modalities, such as Mat Pilates, need to be further studied in terms of their physiological responses. Our aim was to investigate the effects of 12 weeks of Mat Pilates on redox status in postmenopausal women with one or multiple comorbidities of cardiometabolic diseases. Forty-four postmenopausal women were divided into two groups: SINGLE, composed of women with one cardiometabolic disease (n = 20) and MULT, with multimorbidity (n = 24). Mat Pilates training was conducted three times a week for 12 weeks, and each session lasted 50 min. Plasma samples were collected before and after training to analyze the following redox markers: superoxide dismutase, catalase, glutathione peroxidase, total antioxidant capacity due to ferric-reducing antioxidant power (FRAP), reduced glutathione (GSH), uric acid, and carbonyl protein. ANCOVA showed interaction effects in FRAP (p = 0.014). Both groups had reduced levels of catalase (p = 0.240) and GSH (p = 0.309), and increased levels of carbonyl protein (p = 0.053) after intervention. In conclusion, the redox status of postmenopausal women shows no changes mediated by Mat Pilates training between SINGLE and MULT, except for greater reductions of FRAP in SINGLE.Entities:
Keywords: Pilates training; climacteric; endogenous antioxidants; exercise; oxidative stress balance
Year: 2022 PMID: 35892647 PMCID: PMC9331979 DOI: 10.3390/antiox11081445
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Follow-up flowchart.
Exercise load progression.
| Weeks of Training | Exercise Load Progression |
|---|---|
| 1–3rd | 10 repetitions, body weight |
| 4–6th | 12 repetitions, body weight |
| 7–9th | 12 repetitions, shin guards and free weight |
| 10–12th | 15 repetitions, shin guards and free weight |
Baseline general characteristics, drugs, and comorbidities.
| SINGLE | MULT | TOTAL | |
|---|---|---|---|
| Characteristics | |||
| Age (years) | 57 ± 4 | 58 ± 6 | 58 ± 5 |
| Postmenopausal time (years) | 10 ± 6 | 9 ± 7 | 9 ± 7 |
| Waist circumference (cm) | 79 ± 7 | 96 ± 9 * | 84 ± 8 |
| BMI (kg/m2) | 25 ± 3 | 29 ± 4 * | 27 ± 4 |
| Obesity ( | 0 (0) | 11 (46) | 11 (25) |
| Rest SBP (mmHg) | 121 ± 8 | 119 ± 10 | 120 ± 9 |
| Rest DBP (mmHg) | 77 ± 8 | 76 ± 8 | 77 ± 8 |
| Hypertension ( | 3 (15) | 20 (83) | 23 (52) |
| Fasting glucose (mg/dL) | 97 ± 10 | 93 ± 8 | 95 ± 9 |
| Diabetes Mellitus ( | 0 (0) | 0 (0) | 0 (0) |
| Total cholesterol (mg/dL) | 231 ± 40 | 218 ± 35 | 224 ± 37 |
| HDL (mg/dL) | 60 ± 11 | 61 ± 11 | 61 ± 11 |
| LDL (mg/dL) | 142 ± 39 | 135 ± 33 | 138 ± 36 |
| Triglycerides (mg/dL) | 162 ± 89 | 113 ± 44 * | 135 ± 72 |
| Dyslipidemia ( | 17 (85) | 22 (92) | 39 (89) |
| Drugs ( | |||
| Statins | 1 (5) | 1 (4) | 2 (5) |
| ARB | 1 (5) | 6 (5) | 7 (16) |
| ARB + Diuretic | 2 (10) | 7 (29) | 9 (20) |
| Diuretic | 0 (0) | 2 (9) | 2 (5) |
| ACEi | 0 (0) | 4 (17) | 4 (9) |
| ACEi + Diuretic | 0 (0) | 1 (4) | 1 (2) |
| Levothyroxine | 3 (15) | 3 (13) | 6 (14) |
| Number of comorbidities ( | |||
| One | 20 (100) | 0 (0) | 20 (45) |
| Two | 0 (0) | 20 (83) | 20 (43) |
| Three | 0 (0) | 4 (17) | 4 (9) |
Data are presented as mean ± standard deviation or n (%). SINGLE: women with 1 disease; MULT: women with ≥ 2 comorbidities; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; HDL: high density lipoprotein; LDL: low density lipoprotein; ARB: angiotensin receptor blocker; ACEi: Angiotensin Converting Enzyme Inhibitor. * p < 0.05, significant difference between groups. Obesity was considered with BMI ≥ 30 (kg/m2). Diabetes Mellitus was considered with fasting glucose > 126 mg/dL.
Plasma redox status in SINGLE (n = 20) and MULT (n = 24) before and after 12 weeks of Mat Pilates training.
| PRE | POST Adjusted | Mean Difference | ANCOVA | |
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | (95%CI) | ||
| SOD (U/mL) | ||||
| SINGLE | 0.93 ± 0.04 | 0.82 ± 0.16 | −0.11 (−0.16 to −0.06) | 0.972 |
| MULT | 0.88 ± 0.17 | 0.82 ± 1.48 | −0.06 (−0.48 to 0.36) | |
| Catalase (U/μg prot) | ||||
| SINGLE | 1674.48 ± 186.16 | 1097.14 ± 357.57 | −577.34 (−702.27 to −452.41) | 0.240 |
| MULT | 1508.66 ± 598.25 | 967.79 ± 326.21 | −540.87 (−733.64 to −348.1) | |
| GPx (U/mg prot) | ||||
| SINGLE | 1.20 ± 0.07 | 1.11 ± 0.41 | −0.09 (−0.22 to 0.04) | 0.102 |
| MULT | 1.23 ± 0.29 | 0.90 ± 0.38 | −0.33 (−0.47 to −0.19) | |
| FRAP (nmol Trolox) | ||||
| SINGLE | 178.89 ± 5.32 | 157.12 ± 29.70 | −21.77 (−31.12 to −12.42) | 0.014 |
| MULT | 195.58 ± 83.75 | 180.38 ± 27.09 | −15.2 (−40.1 to 9.7) | |
| GSH (nmol/mg prot) | ||||
| SINGLE | 5.96 ± 0.45 | 4.03 ± 1.24 | −1.93 (−2.34 to −1.52) | 0.309 |
| MULT | 6.39 ± 1.68 | 3.64 ± 1.13 | −2.75 (−3.32 to −2.18) | |
| Uric acid (mg/dL) | ||||
| SINGLE | 4.05 ± 0.25 | 3.81 ± 0.76 | −0.24 (−0.49 to 0.01) | 0.418 |
| MULT | 4.22 ± 1.14 | 4.10 ± 0.70 | −0.12 (−0.5 to 0.26) | |
| Carbonylated protein (nmol/mg of protein) | ||||
| SINGLE | 3.05 ± 0.16 | 4.36 ± 1.16 | 1.31 (0.95 to 1.67) | 0.053 |
| MULT | 3.14 ± 0.99 | 4.82 ± 1.06 | 1.68 (1.27 to 2.09) | |
Data are presented as mean ± standard deviation. SINGLE: women with 1 disease; MULT: women with ≥ 2 comorbidities. Data are presented in pre- and post-adjusted. Mean difference from pre- to post-intervention values were calculated from the unadjusted post. SOD: superoxide dismutase; CAT: catalase; GPx: glutathione peroxidase; FRAP: Total antioxidant capacity due to ferric-reducing antioxidant power; GSH: reduced glutathione.
Statistical power of analysis.
| Power | |
|---|---|
| SOD (U/mL) | 0.050 |
| Catalase (U/μg prot) | 0.999 |
| GPx (U/mg prot) | 0.167 |
| FRAP (nmol Trolox) | 0.908 |
| GSH (nmol/mg prot) | 0.999 |
| Uric acid (mg/dL) | 0.277 |
| Carbonylated Protein (nmol/mg of prot) | 0.999 |
SOD: superoxide dismutase; CAT: catalase; GPx: glutathione peroxidase; FRAP: Total antioxidant capacity due to ferric-reducing antioxidant power; GSH: reduced glutathione.